Differences in inhaled fluticasone bioavailability between holding chambers in children with asthma

Pharmacotherapy

Volumn 22, Issue 8, 2002, Pages 947-953

  Liang, Judy ^a   Asmus, Michael J ^a   Hochhaus, Günther ^b   Chesrown, Sarah ^c   Hendeles, Leslie ^a,c  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANE DERIVATIVE; BRONCHODILATING AGENT; FLUTICASONE; FLUTICASONE PROPIONATE;

AEROSOL; AREA UNDER THE CURVE; ARTICLE; ASTHMA; BIOAVAILABILITY; BLOOD; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; NEBULIZER; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; CLINICAL ARTICLE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OUTCOMES RESEARCH;

ADMINISTRATION, INHALATION; AEROSOLS; ANDROSTADIENES; AREA UNDER CURVE; ASTHMA; BIOLOGICAL AVAILABILITY; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; HUMAN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0036021195     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.12.947.33612     Document Type: Article

References (26)

1. Choosing the metered-dose inhaler spacer of holding chamber that matches the patient's need: Evidence that specific drug being delivered is an important consideration
2. Inhalational drug delivery from seven different spacer devices
3. The Spacerhaler for delivery of salbutamol: A comparison with the standard metered-dose inhaler plus Volumatic spacer device
4. Evaluation of aerosol drug output from the OptiChamber and AeroChamber spacers in a model system
5. A comparative analysis of the particle size output of beclomethasone dipropionate, salmeterol xinafoate and fluticasone propionate metered dose inhalers used with the Babyhaler. Volumatic and Aerochamber spacer devices
6. Absorption and metabolism of orally administered beclomethasone dipropionate
7. Flunisolide metabolism and dynamics of a metabolite
8. Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis
9. Pharmacokinetics of triamcinolone acetonide and its phosphate ester
10. Pharmacokinetics of flunisolide administered via metered dose inhaler with and without a spacer device and following oral administration
11. The human pharmacology of fluticasone propionate
12. Oral bioavailability of fluticasone propionate in healthy subjects
13. Evaluation of the buccal component of systemic absorption with inhaled fluticasone propionate
14. Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration
15. Determination of the glucocorticoid fluticasone propionate in plasma by automated solid-phase extraction and liquid chromatography-tandem mass spectrometry
16. An improved method for the determination of fluticasone propionate in human plasma
17. A sensitive LC-MS/MS method for the quantification of fluticasone propionate in human plasma
18. Fluticasone plasma concentrations in children with asthma after deliver by MDI
19. Choosing therapy for childhood asthma
20. Effect of holding chambers on in-vitro respirable dose of fluticasone propionate from a metered-dose inhaler
21. Simultaneous determination of triamcinolone acetonide and hydrocortisone in human plasma by high-performance liquid chromatography
22. In vitro properties of pressured metered dose inhalers with and without spacer devices
23. Lung deposition of budesonide from a pressurized metered-dose inhaler attached to a spacer
24. Comparison of the systemic availability of fluticasone propionate in healthy volunteers and patients with asthma
25. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: A randomized crossover study
26. Respiratory function testing in early childhood: Where have we come from and where are we going?